You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Sanofi Aims to Overturn Order Invalidating Patents in Zolgensma Dispute Patent Dispute Background: The dispute centers on patents associated with Zolgensma, a revolutionary gene therapy medication known for its potential to treat rare genetic disorders. These patents play a critical role... Read the full IIPLA article: https://iipla.org/news/sanofi-aims-to-overturn-order-invalidating-patents-in-zolgensma-dispute